Crossmark

Clinical Trial Endpoints and Their Clinical Meaningfulness in Early Stages of Alzheimer's Disease

Crossref DOI link: https://doi.org/10.14283/jpad.2022.41

Published Print: 2022-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Cohen, Sharon

Cummings, J.

Knox, S.

Potashman, M.

Harrison, J.
License Information

Text and Data Mining valid from 2022-07-01

Text and Data Mining valid from 2022-07-01

Version of Record valid from 2022-04-26
More Information

This article is maintained by: Elsevier

Article Title: Clinical Trial Endpoints and Their Clinical Meaningfulness in Early Stages of Alzheimer's Disease

Journal Title: The Journal of Prevention of Alzheimer's Disease

CrossRef DOI link to publisher maintained version: https://doi.org/10.14283/jpad.2022.41

Content Type: article

Copyright: Copyright © 2022 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS